PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Ciclosporin (Eye Anti Inflammatory)
Presentation Product Chemical substance Chapter Items dispensed
Ciclosporin 1mg/ml eye drops 0.3ml unit dose
1104020AEAAAAAA
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye 13,382
Ciclosporin 0.2% eye ointment
1104020AEAAAGAG
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye 17
Ciclosporin 0.2% eye ointment preservative free
1104020AEAAAFAF
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye 11
Ciclosporin 900microg/ml eye drops 0.25ml ud preserv free
1104020AEAAABAB
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye 11
Ciclosporin 0.05% eye dps 0.4ml unit dose preservative free
1104020AEAAAJAJ
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye 6
Ciclosporin 0.06% eye dps 0.4ml unit dose preservative free
1104020AEAAAIAI
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye No data available
Ciclosporin 0.06% eye drops preservative free
1104020AEAAAHAH
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye No data available
Ciclosporin 2% eye drops
1104020AEAAAEAE
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye No data available
Ciclosporin 2% eye drops preservative free
1104020AEAAADAD
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye No data available
Ciclosporin 2% eye ointment
1104020AEAAACAC
Ciclosporin (Eye Anti Inflammatory) Ciclosporin (Eye Anti Inflammatory) Eye No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.